Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model
Cancer Science · 2024-11 · 115 (11) · 3612-3621
DOI: 10.1111/cas.16324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 08.09.2024. Verfasst von Kenji Nakamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan. Hauptthemen laut MEDLINE: Chromosome Aberrations, Carcinogenesis, Diethylnitrosamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan.
Abstract (Originalsprache)
Chromosome aberrations (CAs), a genotoxic potential of carcinogens, are believed to contribute to tumorigenesis by chromosomal rearrangements through micronucleus formation. However, there is no direct evidence that proves the involvement of CAs in tumorigenesis in vivo. In the current study, we sought to clarify the involvement of CAs in chemical carcinogenesis using a rat model with a pure CA‐inducer hepatocarcinogen, acetamide. Whole‐genome analysis indicated that hepatic tumors induced by acetamide treatment for 26–30 weeks showed a broad range of copy number alterations in various chromosomes. In contrast, hepatic tumors induced by a typical mutagen (diethylnitrosamine) followed by a nonmutagen (phenobarbital) did not show such mutational patterns. Additionally, structural alterations such as translocations were observed more frequently in the acetamide‐induced tumors. Moreover, most of the acetamide‐induced tumors expressed c‐Myc and/or MDM2 protein due to the copy number gain of each oncogene. These results suggest the occurrence of chromosomal rearrangements and subsequent oncogene amplification in the acetamide‐induced tumors. Taken together, the results indicate that CAs are directly involved in tumorigenesis through chromosomal rearrangements in an acetamide‐induced hepatocarcinogenesis rat model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan.
- Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
ORCID-Profile: Yuji Ishii, Makoto Shibutani, Kumiko Ogawa
Förderung
- Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan
Zitieren
APA
Nakamura, K., Ishii, Y., Takasu, S., Namiki, M., Soma, M., Takimoto, N., Matsushita, K., Shibutani, M., & Ogawa, K. (2024). Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model. Cancer Science, 115(11), 3612-3621. https://doi.org/10.1111/cas.16324
Vancouver
Nakamura K, Ishii Y, Takasu S, Namiki M, Soma M, Takimoto N, et al. Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model. Cancer Science. 2024;115(11):3612-3621. doi:10.1111/cas.16324
BibTeX
@article{Nakamura2024,
author = {Nakamura, Kenji and Ishii, Yuji and Takasu, Shinji and Namiki, Moeka and Soma, Meili and Takimoto, Norifumi and Matsushita, Kohei and Shibutani, Makoto and Ogawa, Kumiko},
title = {Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {11},
pages = {3612--3621},
doi = {10.1111/cas.16324}
}
EUVIMED